Lexaria Bioscience Corp. (NASDAQ: LEXX) Advances its Human Nicotine Study and Announces New Nicotine Formulation Creation and Evaluation Program with Altria
April 18, 2022
Lexaria’s patented DehydraTECH(TM) technology has proven, in the NIC-A21-1 animal study, to be 10-20 times faster in reaching peak delivery of nicotine to the bloodstream than controls The company hopes to affirm this in the NIC-H22-1 human nicotine study as their DehydraTECH-nicotine pouch performance will be compared to existing leading brands currently sold in the […]
Cybin Inc. (NEO: CYBN) (NYSE American: CYBN) CYB004 Pipeline Program Receives Key Patent Approval from WIPO
April 18, 2022
World Intellectual Property Organization has published CYBN’s international patent application Publication of patent application demonstrates CYBN’s continued commitment to discovering, developing psychedelic-based treatment options Company continues to see strong protection for growing intellectual property portfolio of psychedelic-based compounds Cybin (NEO: CYBN) (NYSE American: CYBN) announced that the World Intellectual Property Organization (“WIPO”) has published an international […]
InvestorNewsBreaks – Nextech AR Solutions Corp. (CSE: NTAR) (NEO: NTAR) (OTCQB: NEXCF) (FSE: N29) Launches End-to-End SaaS Platform ‘Nextech Metaverse Suite’
April 14, 2022
Nextech (CSE: NTAR) (NEO: NTAR) (OTCQB: NEXCF) (FSE: N29), a metaverse company and leading provider of augmented reality (“AR”) experience technologies and services, today announced its achievement of a major milestone with the launch of the Nextech Metaverse Suite. According to the update, the suite of metaverse software-as-a-service (“SaaS”) products unifies Nextech’s entire technology stack […]
InvestorNewsBreaks – Hollywall Entertainment Inc. (HWAL) Empowering Small Communities to Pursue Concept Central to American Ideals
April 13, 2022
Hollywall Entertainment (OTC: HWAL), an innovative telecommunication and broadcasting company, is focused on ensuring “digital equity” through access to the internet and its resources. “Hollywall president and CEO Darnell Sutton helped to pioneer the concept of ‘Fiber to the People’ as a way of empowering small communities, especially those in the South’s ‘Black Belt,’ to […]
InvestorNewsBreaks – VistaGen Therapeutics Inc. (NASDAQ: VTGN), AffaMed Announce Substantial Progress Toward Initiating PALISADE Global Trial
April 12, 2022
VistaGen (NASDAQ: VTGN) and AffaMed Therapeutics have announced completion of regulatory preparations to initiate PALISADE Global, a phase 3 clinical trial to evaluate the efficacy, safety and tolerability of VistaGen’s PH94B (referred to by AffaMed as “AM005”) for the acute treatment of anxiety in adults with social anxiety disorder (“SAD”), in the U.S. and China. […]
InvestorNewsBreaks – PowerTap Hydrogen Capital Corp. (CSE: MOVE) (FWB: 2K6) (OTC: MOTNF) Subsidiary Creates Advisory Board, Names CEO
April 12, 2022
PowerTap Hydrogen Capital (CSE: MOVE) (FWB: 2K6) (OTC: MOTNF), an investment company, announced that subsidiary Progressus Clean Technologies, formerly AES-100 Inc., has created an advisory board. According to the announcement, the board is tasked with helping the company accelerate technology development and commercialization of its market responsive hydrogen products. World-renowned hydrogen expert Pinakin Patel has […]
Mydecine Innovations Group Inc. (NEO: MYCO) (OTC: MYCOF) (FSE: 0NFA) Provides Business Update, Marking 2021 Achievements
April 12, 2022
In 2021, Mydecine made significant progress in creating and commercializing new treatments for mental health and addiction disorders It also made a noteworthy shift in focus to reducing expenses and increasing efficiencies for continued clinical trials and the expansion of its IP portfolio For 2022, the company plans to build on the progress achieved in […]
Knightscope, Inc. (NASDAQ: KSCP) Celebrates 9th Anniversary; Enters $100M Stock Purchase Agreement with B. Riley Principal Capital
April 11, 2022
The security robot market was valued at $8.87 billion in 2020 and is expected to grow to $19.77 billion by 2026 Knightscope’s autonomous security robots bridge the gap between unmet security needs and the security demands of a rising population The committed equity facility provides Knightscope with the right to sell and issue up to […]
The Sweet Smell of Trash: EverGen Infrastructure Corp. (TSX.V: EVGN) (OTCQB: EVGIF) Growing Profits and a Dominant Position in Canada’s Renewable Natural Gas Market
April 11, 2022
Through three acquisitions, EverGen Infrastructure Corp. has rapidly emerged as a leading player in the RNG market with its specialization in waste-to-energy EverGen owns the first producing RNG facility in Western Canada and calls municipalities and FortisBC as customers EverGen recently signed an LOI to expand into Alberta through the acquisition of 67% of a […]
Correlate Infrastructure Partners, Inc. (OTCQB: CIPI) Completes Name and Ticker Symbol Change from Triccar, Inc. (OTCQB: TCCR)
April 11, 2022
BOISE, Idaho, April 11, 2022 (GLOBE NEWSWIRE) — via InvestorWire — Correlate Infrastructure Partners, Inc. (OTCQB: CIPI) (the Company) today announces it has completed the Company’s corporate name change from Triccar, Inc. to Correlate Infrastructure Partners, Inc. In conjunction with the name change the Company’s ticker symbol will change to “CIPI” effective at the open […]
InvestorNewsBreaks – Exro Technologies Inc. (TSX: EXRO) (OTCQB: EXROF) Announces Milestones, Updates Ahead of Quarterly Webcast
April 8, 2022
Exro Technologies (TSX: EXRO) (OTCQB: EXROF), a leading clean technology company that has developed a new class of power electronics for electric motors and batteries, has announced updates related to a number of the company’s new and ongoing projects that mark important milestones and progress towards the commercialization of its Coil Driver(TM) technology. Shareholders will […]
InvestorNewsBreaks – Save Foods Inc. (NASDAQ: SVFD) (FSE: 80W) Releases Letter to Stockholders
April 6, 2022
Save Foods (NASDAQ: SVFD) (FSE: 80W), an agri-food tech company specializing in eco crop protection that helps reduce food waste and ensure food safety, published a letter to its stockholders from CEO David Palach. “We achieved multiple significant milestones in 2021, successfully transitioning Save Foods from a research and development focused organization to a commercial […]
InvestorNewsBreaks – South Star Battery Metals Corp. (TSX.V: STS) (OTCQB: STSBF) Announces ‘Next Cornerstone’ Toward World-Class Graphite Production
April 5, 2022
South Star (TSX.V: STS) (OTCQB: STSBF) has announced its entry into a binding streaming agreement with Sprott Resource Streaming and Royalty Corp (“SRSR”) for a total cash consideration of up to US$28 million as prepayment for graphite concentrates from the Santa Cruz Graphite Project in Brazil. According to the announcement, South Star will act as […]
InvestorNewsBreaks – Processa Pharmaceuticals Inc. (NASDAQ: PCSA) Enrolls First Patient in PCS12852 Phase 2A Trial
April 5, 2022
Processa Pharmaceuticals (NASDAQ: PCSA), a clinical-stage biopharmaceutical company developing products to improve the survival and/or quality of life for patients with unmet medical needs, today announced that it has enrolled its first patient in the Phase 2A clinical trial of PCS12852 in patients with moderate to severe gastroparesis. A chronic gastric motility disorder in which […]
InnerScope Hearing Technologies Inc. (INND) Seeks to Position for the Launch of the OTC Hearing Aid Law; Inks Agreement with RiteAid.Com
April 5, 2022
InnerScope Hearing Technologies recently announced that subsidiary HearingAssist’s products would be carried by RiteAid.com The distribution agreement with one of the nation’s leading drug store chains comes as InnerScope seeks to position itself to benefit from the upcoming OTC Hearing Aid Law The Hearing Aid Law will create a new category of hearing aids, available […]
IBN (InvestorBrandNetwork) Announces Latest Episode of The Bell2Bell Podcast featuring Doug Heldoorn, Chairman of Advanced Container Technologies Inc.
April 5, 2022
NEW YORK, April 05, 2022 (GLOBE NEWSWIRE) — via InvestorWire – IBN (InvestorBrandNetwork), a multifaceted communications organization engaged in connecting public companies to the investment community, is pleased to announce the release of the latest episode of The Bell2Bell Podcast as part of its sustained effort to provide specialized content distribution via widespread syndication channels. The Bell2Bell Podcast delivers informative updates […]
Cybin Inc. (NEO: CYBN) (NYSE American: CYBN) Begins Recruitment for Study Measuring Ketamine’s Psychedelic Effect
April 5, 2022
Cybin-sponsored study will use Kernel Flow, Kernel’s quantitative neuroimaging. Company hopes to learn more about impact ketamine has on brain activity, overall mental well-being. Study results may lead to future studies supporting CYBN’s mission to develop psychedelics into therapeutics. Cybin’s (NEO: CYBN) (NYSE American: CYBN) efforts to transform the mental-health treatment landscape have reached a key […]
CNS Pharmaceuticals, Inc. (NASDAQ: CNSP) CEO John Climaco Shares Company Highlights, Goals at 2022 Virtual Growth Conference Presented by Maxim Group LLC
April 4, 2022
The three-day event showcased CNS through corporate presentation, fireside chat, and live question and answer sessions CNS has been granted both Orphan Drug Designation and Fast Track status from the FDA for Berubicin in 2020 and 2021, respectively CNS initiated a potentially pivotal global trial of Berubicin for recurrent Glioblastoma Multiforme (“GBM”) with the dosing […]
InvestorNewsBreaks – StraightUp Resources Inc. (CSE: ST) (OTCQB: STUPF) Positioned to Expand Portfolio, Capitalize on Growing Demand for Gold
April 1, 2022
StraightUp Resources (CSE: ST) (OTCQB: STUPF) recently entered into a purchase option agreement that gives it exclusive right and option to acquire from Perry English and Gravel Ridge Resources Ltd. (“Optionors”), a 100% dividend interest in the Ranger/Otter mining project located in Red Lake, Ontario. “This agreement opens an opportunity for StraightUp to grow its […]
InvestorNewsBreaks – Cybin Inc.’s (NYSE American: CYBN) (NEO: CYBN) Adelia Therapeutics Inc. Achieves New Milestone
April 1, 2022
Cybin (NYSE American: CYBN) (NEO: CYBN), a biopharmaceutical company focused on progressing “Psychedelics to Therapeutics(TM),” today announced that Adelia Therapeutics, a wholly controlled subsidiary of Cybin, has achieved the milestone identified as Year 1, Q2 (iv) as contemplated by the terms of a contribution agreement dated Dec. 4, 2020. The transaction agreement was among Cybin, […]
InvestorNewsBreaks – Vivos Therapeutics Inc. (NASDAQ: VVOS) Releases Q4, Full-Year 2021 Financial, Operational Report
April 1, 2022
Vivos Therapeutics (NASDAQ: VVOS), a medical technology company focused on developing and commercializing a suite of innovative diagnostic and treatment modalities for patients with dentofacial abnormalities and/or mild to moderate obstructive sleep apnea (“OSA”) and snoring in adults, is reporting its financial results and operating highlights for the fourth quarter and full year ended Dec. […]
InvestorNewsBreaks – GreenBox POS (NASDAQ: GBOX) Releases Q4, FY 2021 Financial Report, Operational Highlights
April 1, 2022
GreenBox (NASDAQ: GBOX), an emerging and rapidly growing fintech company, is reporting financial results for the fourth quarter and full year for the period ended Dec. 31, 2021. Report highlights include record revenue for the company, which totaled $26.3 million for the year; an increase of $17.8 million or 208.6% over the $8.5 million reported in […]
InvestorNewsBreaks – Vivos Therapeutics Inc. (NASDAQ: VVOS) Announces Call to Review Q4, FY 2021 Financial Results
March 31, 2022
Vivos Therapeutics (NASDAQ: VVOS), a medical technology company focused on developing and commercializing a suite of innovative diagnostic and treatment modalities for patients with dentofacial abnormalities and/or mild-to-moderate obstructive sleep apnea (“OSA”) and snoring, has scheduled a conference call to discuss financial results that will be reported today after market close. The financial results will […]
InvestorNewsBreaks – Genprex Inc. (NASDAQ: GNPX) Opens Acclaim-2 Clinical Trial for Patient Enrollment
March 31, 2022
Genprex (NASDAQ: GNPX), a clinical-stage gene therapy company focused on developing life-changing treatments for patients with cancer and diabetes, has announced the opening for patient enrollment of its Acclaim-2 clinical trial. According to the update, Acclaim-2 is an open-label, multi-center phase 1/2 clinical trial evaluating the company’s lead drug candidate, REQORSA(TM) Immunogene Therapy, in combination […]
InvestorNewsBreaks – Processa Pharmaceuticals Inc. (NASDAQ: PCSA) Releases Year-End 2021 Financial, Corporate Results
March 31, 2022
Processa Pharmaceuticals (NASDAQ: PCSA), a clinical stage company developing drugs for patients who have unmet medical conditions that require better treatment options to improve survival and/or quality of life, has reported its financial numbers and corporate highlights for 2021 year end. Highlights of the report included the success of the company’s next-generation capecitabine Phase 1B […]
Red White & Bloom Brands Inc. (CSE: RWB) (OTCQX: RWBYF) Continues to Focus on the Continued Growth of its Top-Line Revenue and Bottom-Line Results in a Move to achieve its 3-Year Success Plan
March 31, 2022
RWB’s mission has always been to become the superior and most recognizable cannabis company in the United States It seeks to achieve this by focusing on the continued growth of top-line revenue and bottom-line results through brand expansion, mergers, and acquisitions So far, in 2022, the company has announced the acquisition of PharmaCo, which sees […]
CNS Pharmaceuticals, Inc. (NASDAQ: CNSP) Reiterates Commitment to Operational Excellence, Advancing Berubicin Recognition
March 31, 2022
In a video message to shareholders, CEO John Climaco detailed the operational and clinical progress made by lead drug candidate Berubicin despite market volatility and share price fluctuations CNS is currently enrolling patients into a potentially pivotal global drug trial of Berubicin for recurrent glioblastoma multiforme Interim analysis of the trial is currently expected as […]
InvestorNewsBreaks – Exro Technologies Inc. (TSX.V: EXRO) (OTCQB: EXROF) Releases Q4 2021 Financial Report
March 30, 2022
Exro Technologies (TSX.V: EXRO) (OTCQB: EXROF), a leading clean-technology company that has developed a new class of power electronics for electric motors and batteries, has reported financial numbers and operational milestones for the fourth quarter 2021. Highlights of the report include the fact that Exro R&D activities increased twofold during 2021 as the company worked […]
Silo Pharma Inc. (SILO) Is ‘One to Watch’
March 30, 2022
Silo recently extended its option with the University of Maryland, Baltimore to explore arthritogenic joint-homing peptides and their use in arthritis-inflamed joints In December 2021, the company announced the issuance of a patent relating to its University of Maryland, Baltimore licensed homing peptide for enhanced targeting of therapeutic agents to the central nervous system The […]
Eat Well Investment Group Inc. (CSE: EWG) (OTC: EWGFF) Shores Up Food Supply Chain During Disruptive Era, Maintains Revenue Growth Forecast
March 30, 2022
Eat Well Investment Group Inc. is a rapid-growth supplier of nutritious, plant-based food products for people and pets Amid large disruptions to global food security occasioned by the COVID-19 pandemic and war in Ukraine, Eat Well is working to overcome supply chain obstacles to further its mission of supplying the world with nutritious, life-enhancing food […]
InvestorNewsBreaks – Cybin Inc. (NYSE American: CYBN) (NEO: CYBN) Announces Significant Milestone Toward Advancing CYB003 Program
March 29, 2022
Cybin (NYSE American: CYBN) (NEO: CYBN), a biopharmaceutical company focused on progressing “Psychedelics to Therapeutics(TM),” today announced the completion of in vivo preclinical studies evaluating its deuterated psilocybin analog CYB003 for the potential treatment of major depressive disorder (“MDD”). According to the update, data from the studies demonstrate that CYB003 is well-tolerated following several doses […]
CNS Pharmaceuticals, Inc. (NASDAQ: CNSP) Provides Update on Advances in Brain Cancer Drugs and Operational Financials
March 29, 2022
Texas-based CNS Pharmaceuticals is a novel brain cancer drug developer that is building a series of global clinical trials for its lead drug candidate, Berubicin CNS began dosing patients in a global trial last September to evaluate Berubicin in treating glioblastoma multiforme (“GBM”), currently an incurable brain cancer CNS received FDA Fast Track designation for […]
Hero Technologies Inc. (HENC) CEO Talks ‘Foot in the Door’ Acquisitions in Recent Bell2Bell Podcast
March 29, 2022
HENC is focusing on expansion of current operations, future growth in industry Company aims to be a low-cost, nationally and internationally branded company, become true multistate operator (“MSO”) Recent podcast provides overview of company’s strategic plans, important milestones Key acquisitions and investments have played an essential role in Hero Technologies’ (OTC: HENC) strategic business plan and […]
ECGI Approaching Key Strategic Milestones in the Cannabinoid Marketplace
March 29, 2022
LOS ANGELES, March 29, 2022 (GLOBE NEWSWIRE) — via InvestorWire – ECGI HOLDINGS INC. (OTC: ECGI) (“ECGI” or the “Company”), D/B/A Elite Cannabis Group Incorporated, a Nevada-based portfolio company pivoting into the legal cannabis and cannabinoid marketplace, is pleased to offer current and prospective shareholders with the following update on the Company’s operations. “We are working to […]
InvestorNewsBreaks — Mullen Automotive Inc. (NASDAQ: MULN) Announces Expected Report, Strengthened Balance Sheet
March 28, 2022
Mullen Automotive (NASDAQ: MULN), an emerging electric vehicle (“EV”) manufacturer, expects to report more than $65 million in cash and cash equivalents when it files Form 10Q for second quarter, the period ending March 31, 2022. The company has made significant progress and taken milestone steps during the quarter, including beginning trading on the Nasdaq […]
InvestorNewsBreaks – TAAT(TM) Global Alternatives Inc. (CSE: TAAT) (OTCQB: TOBAF) (FRANKFURT: 2TP2) Finalizes Registered Trademarks in Eight Markets Around the World
March 28, 2022
TAAT(TM) Global Alternatives (CSE: TAAT) (OTCQB: TOBAF) (FRANKFURT: 2TP2) announced that it has obtained registered trademark status in eight global markets. The company had applied for trademark registration for its TAAT(R) brand name in the United States, the European Union, Australia, New Zealand, the Philippines, Israel, India and Mexico. TAAT began the process of trademark protection […]
InvestorNewsBreaks – StraightUp Resources Inc. (CSE: ST) (OTCQB: STUPF) Focused on Executing 2022 Plans, Including New Acquisitions, Expanded Market Reach
March 25, 2022
StraightUp Resources (CSE: ST) (OTCQB: STUPF) recognizes the issues posed by the Ukraine crisis, which, though focused on Eastern Europe, is affecting various sectors globally. “Despite its properties being located in North America, the developments in Russia and Ukraine, coupled with the former’s sanctions, are affecting its operations and its shareholders’ willingness to take more […]
InvestorNewsBreaks – Hollywall Entertainment Inc. (HWAL) Creating One-of-a-Kind Digital System as NFTs are Set to Transform Music Industry
March 25, 2022
Hollywall Entertainment (OTC: HWAL), an innovative telecommunications and broadcasting company, understands the inherent value of non-fungible tokens (“NFTs”), which are poised to transform the music industry by facilitating equitable compensation for artists and enhancing the potential for remixes and collaborations. The company also understands that NFTs are becoming an integral part of how fans can […]
InvestorNewsBreaks – Cybin Inc. (NEO: CYBN) (NYSE American: CYBN) Subsidiary Achieves Milestone Outlined in Contribution Agreement
March 25, 2022
Cybin (NEO: CYBN) (NYSE American: CYBN), a biopharmaceutical company focused on progressing Psychedelics to Therapeutics(TM), has announced that its wholly controlled subsidiary, Adelia Therapeutics Inc., has achieved a key milestone. The milestones were identified in the Dec. 4, 2020, contribution agreement between Cybin and Adelia and include Year 1 Q4 (vi), Year 2 Q2 (ii), Year […]
Flora Growth Corp. (NASDAQ: FLGC) Reaches Agreements Green-Lighting High-THC Cannabis Exports from Colombia, and Outlets for Premium CBD Skin Care Product in Asia
March 25, 2022
Cannabis product cultivator Flora Growth Corp. operates a premium growing facility in central Colombia and has received a growing list of authorizations to export its cannabis products for varied health and wellness purposes Flora Growth’s authorized distribution of low-THC CBD cannabis derivatives has been recently expanded to include a quota of up to 43,600 kg […]